Livanova Plc (LIVN)

Mar 26, 2025

LivaNova to Announce First-Quarter 2025 Results - Business Wire

Mar 26, 2025

Mar 25, 2025

LivaNova (NASDAQ:LIVN) investors are sitting on a loss of 50% if they invested three years ago - Yahoo Finance

Mar 25, 2025

Mar 21, 2025

Should You Think About Buying LivaNova PLC (NASDAQ:LIVN) Now? - Simply Wall St

Mar 21, 2025

Mar 19, 2025

LivaNova PLC (LIVN) Shares Up 0.4% on Mar 19 - GuruFocus.com

Mar 19, 2025

Mar 19, 2025

Vagus Nerve Stimulators Market is Expected to Witness Positive Growth With A CAGR of 9.06% by 2030, estimates DelveInsight - The Globe and Mail

Mar 19, 2025

Mar 19, 2025

Vagus Nerve Stimulators Market is Expected to Witness Positive - openPR

Mar 19, 2025

Mar 18, 2025

Jefferies cuts Livanova stock price target to $74 from $80 - Investing.com India

Mar 18, 2025

Mar 18, 2025

Barclays maintains Livanova stock with $56 target, cites clarity By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 18, 2025

Jefferies cuts Livanova stock price target to $74 from $80 By Investing.com - Investing.com Australia

Mar 18, 2025

Mar 17, 2025

LivaNova to record $363 million liability after court ruling By Investing.com - Investing.com Australia

Mar 17, 2025

Mar 17, 2025

Needham maintains Livanova buy rating, $64 target amid liability By Investing.com - Investing.com Australia

Mar 17, 2025

Mar 17, 2025

Barclays Maintains Livanova (LIVN) at Equalweight - StreetInsider.com

Mar 17, 2025

Mar 17, 2025

Barclays Starts Livanova (LIVN) at Equalweight - StreetInsider.com

Mar 17, 2025

Mar 17, 2025

Needham maintains Livanova buy rating, $64 target amid liability - Investing.com

Mar 17, 2025

Mar 17, 2025

LivaNova to record $363 million liability after court ruling - Investing.com

Mar 17, 2025

Mar 17, 2025

LivaNova Faces €333 Million Liability Ruling - TipRanks

Mar 17, 2025

Mar 17, 2025

Supreme Court Rules LivaNova Not Liable For 157 Mln Euros Payments In Environmental Liabilities Case - Marketscreener.com

Mar 17, 2025

Mar 13, 2025

LivaNova PLC (NASDAQ:LIVN) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Mar 13, 2025

Mar 12, 2025

LivaNova’s SWOT analysis: medical tech firm’s stock faces growth and legal hurdles - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

Cardiovascular Devices Market Booming with Technological - openPR

Mar 12, 2025

Mar 12, 2025

Autotransfusion Devices and Consumables Market is Estimated - openPR

Mar 12, 2025

Mar 12, 2025

LivaNova’s SWOT analysis: medical tech firm’s stock faces growth and legal hurdles By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 12, 2025

LivaNova PLC (NASDAQ:LIVN) Shares Sold by Bank of New York Mellon Corp - Defense World

Mar 12, 2025

Mar 12, 2025

Vagus Nerve Stimulators Market Generated Opportunities, - openPR

Mar 12, 2025

Mar 12, 2025

LivaNova at Barclays Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

LivaNova at Barclays Conference: Strategic Growth and Innovation - Investing.com India

Mar 11, 2025

Mar 11, 2025

When the Price of (LIVN) Talks, People Listen - Stock Traders Daily

Mar 11, 2025

Mar 10, 2025

Goldman Sachs maintains Livanova buy rating, $55 target By Investing.com - Investing.com UK

Mar 10, 2025

Mar 10, 2025

Barclays Cuts LivaNova (NASDAQ:LIVN) Price Target to $56.00 - Defense World

Mar 10, 2025

Mar 09, 2025

Mutual of America Capital Management LLC Sells 663 Shares of LivaNova PLC (NASDAQ:LIVN) - Defense World

Mar 09, 2025

Mar 07, 2025

Livanova PLC to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 07, 2025

LivaNova stock hits 52-week low at $40.36 amid market challenges - Investing.com Australia

Mar 07, 2025

Mar 06, 2025

LivaNova stock hits 52-week low at $40.36 amid market challenges By Investing.com - Investing.com South Africa

Mar 06, 2025

Mar 06, 2025

Medical Implants Market Set to Witness Significant Growth by 2025-2032: Biotronik, Inc., Livanova Plc, - EIN News

Mar 06, 2025

Mar 05, 2025

LivaNova's (NASDAQ:LIVN) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Mar 05, 2025

Mar 05, 2025

Latin America Vagus Nerve Stimulation Market Report, 2030 - Grand View Research

Mar 05, 2025

Mar 04, 2025

Is LivaNova PLC (LIVN) the Best Medical Technology Stock to Buy According to Analysts? - Insider Monkey

Mar 04, 2025

Mar 04, 2025

After M&A Boondoggles, Livanova Refocuses on Core Businesses - Morningstar

Mar 04, 2025

Mar 04, 2025

LivaNova (NASDAQ:LIVN) Given New $55.00 Price Target at The Goldman Sachs Group - Defense World

Mar 04, 2025

Mar 03, 2025

Cardiac Surgery Devices Market Size, Share, Industry Trends, - openPR

Mar 03, 2025

Mar 02, 2025

LivaNova PLC (NASDAQ:LIVN) Stock Holdings Boosted by Principal Financial Group Inc. - Defense World

Mar 02, 2025

Mar 01, 2025

LivaNova (NASDAQ:LIVN) Given New $60.00 Price Target at Mizuho - MarketBeat

Mar 01, 2025

Mar 01, 2025

Needham & Company LLC Has Lowered Expectations for LivaNova (NASDAQ:LIVN) Stock Price - MarketBeat

Mar 01, 2025

Mar 01, 2025

LivaNova (NASDAQ:LIVN) Issues FY 2025 Earnings Guidance - MarketBeat

Mar 01, 2025

Mar 01, 2025

LivaNova (NASDAQ:LIVN) Cut to “Peer Perform” at Wolfe Research - Defense World

Mar 01, 2025

Mar 01, 2025

LivaNova (NASDAQ:LIVN) Hits New 12-Month LowTime to Sell? - MarketBeat

Mar 01, 2025

Mar 01, 2025

7 Best Medical Technology Stocks To Buy According To Analysts - Insider Monkey

Mar 01, 2025

Feb 28, 2025

Stifel Nicolaus Lowers LivaNova (NASDAQ:LIVN) Price Target to $60.00 - MarketBeat

Feb 28, 2025

Feb 28, 2025

LivaNova (NASDAQ:LIVN) Issues FY25 Earnings Guidance - MarketBeat

Feb 28, 2025

Feb 28, 2025

LivaNova (NASDAQ:LIVN) Stock Rating Lowered by Wolfe Research - MarketBeat

Feb 28, 2025

Feb 28, 2025

How To Trade (LIVN) - Stock Traders Daily

Feb 28, 2025